Most Recent Articles by Helen Fosam
Researchers recently identified 5 key challenges that collectively hinder the design of amyotrophic lateral sclerosis clinical trials and the development of new treatments.
Withholding negative research results not only skews scientific evidence but also puts into question the whole validity of medical research.
While several theories have evolved over the years, none have unequivocally provided robust evidence to fully explain the clinical spectrum of migraine.
Neurology Advisor Articles
- FDA Approves Expanded Treatment Window for Clot Retrieval Device in Acute Ischemic Stroke
- Genetic and Imaging Markers in Migraine: Ready for Prime Time?
- Intracerebral Hemorrhage-Related Hospital Mortality Reduced With Prior NOAC Use
- Resting Tremor Most Common in Early Parkinson Disease
- Erenumab for Episodic Migraine: A Closer Look at the Data
- Updated Ischemic Stroke Guidelines: Expert Takeaways
- Alternative Genetic Risk Variant for Alzheimer Disease Identified
- Advance Directives for Dementia: Honoring Patient Wishes When You Don't Know What They Are
- Ethical Considerations in New Coma Research
- Poor Sleep Associated With Worse PTSD, Chronic Pain in Youth
- Shortcomings in ALS Research: Strategies for Improvement
- Treatments Vary in Trigeminal Neuralgia
- Premature Dementia Risk Increased in Those With Heart Defects
- Are Casual Observers Able to Accurately Localize Areas of Facial Paralysis?
- Adolescents With Chronic Headache May Benefit From Targeted Group Education